< Terug naar vorige pagina
Onderzoeker
Lisa Moris
- Disciplines:Urologie en nefrologie niet elders geclassificeerd, Andrologie, Kankerbiologie
Affiliaties
- Departement Cellulaire en Moleculaire Geneeskunde (Departement)
Lid
Vanaf2 aug 2020 → 14 jun 2022 - Laboratorium voor Moleculaire Endocrinologie (Afdeling)
Lid
Vanaf1 aug 2016 → 31 jul 2020
Projecten
1 - 1 of 1
- Klinische en pre-klinische studies van modulatoren van hoog-risico prostaatkanker met metastatisch potentieelVanaf1 aug 2016 → 29 apr 2022Financiering: BOF - doctorale mandaten, Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
1 - 10 van 53
- Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review(2022)
Auteurs: Lisa Moris
Pagina's: 690 - 700 - Genomic Features of Lung-Recurrent Hormone-Senstive Prostate Cancer(2022)
Auteurs: Lisa Moris
- Patient- and Tumour-related Prognostic Factors for Urinary Incontinence After Radical Prostatectomy for Nonmetastatic Prostate Cancer: A Systematic Review and Meta-analysis(2022)
Auteurs: Lisa Moris
Pagina's: 674 - 689 - Clinical and preclinical studies of modulators of high-risk prostate cancer with metastatic potential(2022)
Auteurs: Lisa Moris, Frank Claessens, Steven Joniau
- Antizyme Inhibitor 1 Regulates Matrikine Expression and Enhances the Metastatic Potential of Aggressive Primary Prostate Cancer(2022)
Auteurs: Lisa Moris, Bram Boeckx, Diether Lambrechts, Christine Helsen, Stefaan Soenen, Elien Smeets, Roy Eerlings, Sarah El Kharraz, Hendrik Van Poppel, Steven Joniau, et al.
Pagina's: 527 - 541 - Systematic Review of Active Surveillance for Clinically Localised Prostate Cancer to Develop Recommendations Regarding Inclusion of Intermediate-risk Disease, Biopsy Characteristics at Inclusion and Monitoring, and Surveillance Repeat Biopsy Strategy(2022)
Auteurs: Lisa Moris
Pagina's: 337 - 346 - Diagnostic and prognostic factors in patients with prostate cancer: a systematic review(2022)
Auteurs: Lisa Moris
- Small-molecule profiling for steroid receptor activity using a universal steroid receptor reporter assay(2022)
Auteurs: Roy Eerlings, Tien Nguyen, Elien Smeets, Lisa Moris, Sarah El Kharraz, Arnout Voet, Wim Dehaen, Frank Claessens, Christine Helsen
- Updating and Integrating Core Outcome Sets for Localised, Locally Advanced, Metastatic, and Nonmetastatic Castration-resistant Prostate Cancer: An Update from the PIONEER Consortium(2022)
Auteurs: Lisa Moris
Pagina's: 503 - 514 - Neoadjuvant hormonal therapy before radical prostatectomy in high-risk prostate cancer(2021)
Auteurs: Gaëtan Devos, Gert De Meerleer, Marcella Baldewijns, Lisa Moris, Hendrik Van Poppel, Charlien Berghen, Wouter Everaerts, Frank Claessens, Steven Joniau
Pagina's: 739 - 762